Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AP1B1 pseudogene 2 (AP1B1P2) is a non-protein-coding genomic sequence annotated as a pseudogene of the adaptor protein complex 1 beta 1 subunit (AP1B1). Pseudogenes are segments of DNA resembling functional genes but are typically nonfunctional due to mutations, truncations, or lack of key regulatory elements. AP1B1P2 does not produce a functional adaptin protein and is not implicated in any known biological processes, disease roles, or as a therapeutic target[4]. AP1B1, the protein-coding gene, encodes a subunit of the clathrin adaptor protein complex 1 (AP-1), which is involved in vesicle-mediated transport and protein sorting in the Golgi and endosomal pathways[2][3][1]. AP1B1P2 is distinct as it is not a protein-coding gene and lacks functional relevance in cell biology or disease. AP1B1P2 is listed explicitly as a "pseudogene" in major databases (GeneCards, NCBI), reinforcing its nonfunctional status[4]. There is no evidence that "AP1B1 pseudogene 2" is a drug target, biomarker, or has any disease association or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AP1B1 pseudogene 2 (AP1B1P2).